Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABO Blood Group Type Association With COVID-19 Severity - A Single Center Study

NCT05859958 is registered in ClinicalTrials.gov with Arrowhead Regional Medical Center as lead sponsor.

NCT NCT05859958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05859958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABO Blood Group Type Association With COVID-19 Severity - A Single Center Study
Lead sponsor
Arrowhead Regional Medical Center
Phase
Observational
Overall status
Completed
Start date
November 10, 2022
Completion date
May 10, 2023
Enrollment
599 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood group antigen abnormality, blood group incompatibilities, covid-19, covid-19 pandemic, diabetes mellitus